As of 2026-09-23, the EV/EBITDA ratio of Apyx Medical Corp (APYX) is -50.05. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Apyx's latest enterprise value is 131.37 mil USD. Apyx's TTM EBITDA according to its financial statements is -2.62 mil USD. Dividing these 2 quantities gives us the above Apyx EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 16.4x | 14.9x |
| Forward P/E multiples | 17.8x - 20.7x | 18.8x |
| Fair Price | (1.30) - (1.21) | (1.24) |
| Upside | -144.1% - -141.0% | -142.1% |
| Date | EV/EBITDA |
| 2026-09-18 | -51.80 |
| 2026-09-17 | -51.32 |
| 2026-09-16 | -51.00 |
| 2026-09-15 | -50.20 |
| 2026-09-14 | -51.16 |
| 2026-09-11 | -49.25 |
| 2026-09-10 | -49.09 |
| 2026-09-09 | -51.64 |
| 2026-09-08 | -51.64 |
| 2026-09-04 | -51.64 |
| 2026-09-03 | -51.80 |
| 2026-09-02 | -52.12 |
| 2026-09-01 | -51.64 |
| 2026-08-31 | -51.64 |
| 2026-08-28 | -52.12 |
| 2026-08-27 | -50.84 |
| 2026-08-26 | -51.64 |
| 2026-08-25 | -52.60 |
| 2026-08-24 | -52.12 |
| 2026-08-21 | -52.76 |
| 2026-08-20 | -51.32 |
| 2026-08-19 | -53.24 |
| 2026-08-18 | -52.60 |
| 2026-08-17 | -51.80 |
| 2026-08-14 | -51.32 |
| 2026-08-13 | -51.48 |
| 2026-08-12 | -50.68 |
| 2026-08-11 | -51.16 |
| 2026-08-10 | -58.19 |
| 2026-08-07 | -67.61 |
| 2026-08-06 | -69.36 |
| 2026-08-05 | -69.04 |
| 2026-08-04 | -71.28 |
| 2026-08-03 | -69.68 |
| 2026-07-31 | -68.41 |
| 2026-07-30 | -68.73 |
| 2026-07-29 | -64.25 |
| 2026-07-28 | -64.57 |
| 2026-07-27 | -65.05 |
| 2026-07-24 | -65.53 |
| 2026-07-23 | -64.09 |
| 2026-07-22 | -65.37 |
| 2026-07-21 | -68.73 |
| 2026-07-20 | -67.93 |
| 2026-07-17 | -71.28 |
| 2026-07-16 | -72.24 |
| 2026-07-15 | -73.51 |
| 2026-07-14 | -70.32 |
| 2026-07-13 | -70.96 |
| 2026-07-10 | -72.88 |